Pfad >>

HALIX

Profile

HALIX, a corporate venture and spin-off of HAL Allergy, is a contract development and manufacturing organization (CDMO), based in Leiden (The Netherlands). The company is licensed for the contract manufacturing of clinical and commercial medicines according to GMP standards. HALIX leverages advanced biopharmaceutical technologies and provides the full portfolio of pharmaceutical documentation of GMP production processes, as well as production of units which are required for clinical approval. HALIX, as an end-to-end service provider, will serve its customers the full range from the first development steps to start of commercial production after successful registration of products.

Headquarter

Leiden, Niederlande
 

Value Enhancement Strategy

  • "HALIX" brand development
  • Expansion: building a new, highly efficient pharmaceutical facility
  • Establishment as an end-to-end service provider
  • Increasing USP: excellent service quality

 

Sector

Contract Development and Manufacturing Organization (CDMO)

Acquisition of share

Corporate Venture and Spin-off of the HAL Allergy (spin-off in December 2012)
 

Website

www.halix.nl

Management Team

HALIX

Alex Huybens

Chief Executive Officer

Mail

VIDEOS
HALIX

New cGMP facility

Since the ground breaking in July 2018, construction activities have been performed within 18 month time.

Start video

HALIX

ALEX HUYBENS

Managing Director

GMP Manufacturing of Proteins and Viruses

Start video

back to top
WHAT WE DO Portfolio HALIX
close